$1.28
-0.12-8.57%
Regentis Biomaterials Ltd (RGNT) Stock Price, Quote, News & History
RGNTAMEX
Regentis Biomaterials Ltd. (RGNT) stock rises after withdrawing its Form F-1 registration statement and accelerating European commercialization for GelrinC.
You can purchase shares of Regentis Biomaterials (AMEX:RGNT) through any online brokerage.
Other companies in Regentis Biomaterials’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Regentis Biomaterials to provide a consensus price target.
The stock price for Regentis Biomaterials (AMEX: RGNT) is $ last updated .
There are no upcoming dividends for Regentis Biomaterials.
Regentis Biomaterials does not have any upcoming earnings scheduled.
There is no upcoming split for Regentis Biomaterials.
Regentis Biomaterials is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on...
